In 2020, Shoji [29] demonstrated that tear levels of CCL17/TARC, CCL24/eotaxin-2, and IL-16 in VKC and AKC patients were significantly higher than in patients with other allergic conjunctivitis, like SAC and PAC (p < 0.01). This evidence concerns the gene CCL17 and atopic conjunctivitis.